Systemic and large local reactions during subcutaneous grass pollen immunotherapy in children

被引:11
作者
Gur Cetinkaya, Pinar [1 ]
Kahveci, Melike [1 ]
Esenboga, Saliha [1 ]
Karaatmaca, Betul [1 ]
Soyer, Ozge [1 ]
Sekerel, Bulent Enis [1 ]
Tuncer, Ayfer [1 ]
Sahiner, Umit Murat [1 ]
机构
[1] Hacettepe Univ, Fac Med, Dept Pediat, Div Pediat Allergy & Asthma Unit, Ankara, Turkey
关键词
adverse reactions; allergic rhinitis; children; pollen; subcutaneous immunotherapy; ALLERGEN IMMUNOTHERAPY; FATAL REACTIONS; RISK-FACTORS; EXTRACTS; IMPACT; INJECTIONS; RHINITIS;
D O I
10.1111/pai.13261
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background Subcutaneous immunotherapy (SCIT) is the allergen-specific curative treatment of allergic rhinitis. Adverse effects, most of which are local, can be observed during the immunotherapy. These adverse effects have been reported more frequently during the pollen season. The purpose of this study was to estimate the rate of local, large local, and systemic reactions during the treatment, to determine the relationship between adverse reactions and the season in which these reactions occur, as well as the risk factors for adverse reactions during the grass pollen-specific SCIT treatment in children. Methods We retrospectively collected and analyzed the data of 261 children who administered grass pollen SCIT between 2008 and 2018. Results A total of 261 children (177, 67.8% male), who received grass pollen SCIT, with a mean (+/- SD) age of 12.0 +/- 3.0 years at the initiation of SCIT were enrolled to the study. The number of the patients who experienced local and large local reactions was 109 and 30, respectively. In addition, the number of the patients with systemic reactions was 35. After the 12 284 injections, local reactions occurred in 357 (2.9%), and this was followed by systemic reaction as 55 (0.4%) and large local reactions as 40 (0.3%). Frequency of local (P 001) and systemic reactions (P = .003) was higher during grass pollen season than out of the grass pollen season. In multivariate analysis, initiation of SCIT during the grass pollen season [OR:7.351, 95%CI:1.532-35.279, P = .013] and experiencing local reactions [OR:4.214, 95%CI:2.159-8.224, P < .001] were independent predictors for the development of large local and systemic reactions. Conclusion SCIT, in which only mild-to-moderate systemic reactions occurred, is safe for the treatment of allergic rhinitis in children. Our study revealed that previous local reactions and initiation of immunotherapy during the grass pollen season were the predictors for large local and systemic reactions during SCIT in children.
引用
收藏
页码:643 / 650
页数:8
相关论文
共 50 条
  • [41] Adverse Events During Immunotherapy Against Grass Pollen-Induced Allergic Rhinitis - Differences Between Subcutaneous and Sublingual Treatment
    Aasbjerg, Kristian
    Dalhoff, Kim Peder
    Backer, Vibeke
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 117 (02) : 73 - 84
  • [42] Grass pollen allergy as an anaphylaxis cofactor during peanut oral immunotherapy
    Chua, Gilbert T.
    Chan, Edmond S.
    Soller, Lianne
    Cameron, Scott B.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (02) : 263 - 264
  • [43] Systemic reactions to immunotherapy during mountain cedar season: implications for seasonal dose adjustment
    Wong, Priscilla H.
    Quinn, James M.
    Gomez, Robert A.
    Webb, Charles N.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (05) : 1438 - +
  • [44] Nonfatal systemic reactions to subcutaneous immunotherapy: A 10-year experience
    Ragusa, FV
    Passalacqua, G
    Gambardella, R
    Campanari, S
    Barbieri, MM
    Scordamaglia, A
    Canonica, GW
    [J]. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY & CLINICAL IMMUNOLOGY, 1997, 7 (03) : 151 - 154
  • [45] Frequency of adverse reactions after subcutaneous allergen immunotherapy in children
    Sasihuseyinoglu, Ayse Senay
    Dogrul, Dilek
    Altintas, Derya Ufuk
    [J]. ENT UPDATES, 2020, 10 (03): : 396 - 401
  • [46] Lack of detectable alterations in immune responses during sublingual immunotherapy in children with seasonal allergic rhinoconjunctivitis to grass pollen
    Rolinck-Werninghaus, C
    Kopp, M
    Liebke, C
    Lange, J
    Wahn, U
    Niggemann, B
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2005, 136 (02) : 134 - 141
  • [47] An observational cohort study of the use of five-grass-pollen extract sublingual immunotherapy during the 2015 pollen season in France
    Blin, Patrick
    Demoly, Pascal
    Drouet, Martine
    Falissard, Bruno
    Lignot-Maleyran, Severine
    Maizi, Helene
    Lorrain, Simon
    Lassalle, Regis
    Droz-Perroteau, Cecile
    Moore, Nicholas
    Molimard, Mathieu
    [J]. ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2018, 14
  • [48] Peripheral blood mononuclear cell transcriptome profile in a clinical trial with subcutaneous, grass pollen allergoid immunotherapy
    Starchenka, Sviatlana
    Oluwayi, Kemi
    Heath, Matthew
    Armfield, Oliver
    Shamji, Mohamed
    Layhadi, Janice
    Lis, Katarzyna
    Cadavez, Lisa
    Rusyn, Olesya
    Skinner, Murray
    De Kam, Pieter-Jan
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2024, 54 (02) : 130 - 142
  • [49] Efficacy of Sublingual Swallow Immunotherapy in Children with Rye Grass Pollen Allergic Rhinitis: A Double-blind Placebo-Controlled Study
    Ahmadiafshar, Akefeh
    Maarefvand, Mina
    Taymourzade, Babak
    Mazloomzadeh, Saeedeh
    Torabi, Zohreh
    [J]. IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2012, 11 (02) : 175 - 181
  • [50] miRNA profiles change during grass pollen immunotherapy irrespective of clinical outcome
    Specjalski, Krzysztof
    Maciejewska, Agnieszka
    Romantowski, Jan
    Pawlowski, Ryszard
    Jassem, Ewa
    Niedoszytko, Marek
    [J]. IMMUNOTHERAPY, 2022, 14 (06) : 433 - 444